logo
  

Regal Beloit To Shut Down Two Kentucky Facilities

Electrical motor and generator maker Regal Beloit Corp.(RBC), Thursday announced plans to close operations at two manufacturing facilities in Kentucky, which will result in the layoff of 200 employees.

The Beloit, Wisconsin-based company said it has decided to stop operations at Mt. Sterling and Winchester, Kentucky facilities. The company will shift the products and processes located at these facilities to other facilities. Regal Beloit expect the restructuring to impact jobs of about 200 employees.

Regal believes that closure of these facilities will enable it remain globally competitive, reduce variation between manufacturing facilities and improve cycle times.

Last month, Regal had a reported a 12 percent decline in profit for the first quarter, despite higher sales, hurt by higher expense, lower margins and one-time charges.

Regal Beloit manufactures electric motors, mechanical and electrical motion controls and power generation products. It has manufacturing, sales and service facilities throughout the US, Canada, Mexico, Europe and Asia.

RBC is currently trading at $77.67, up $0.98 or 1.28%, on a volume of 15 thousand shares on the NYSE. For the past 52-week period, the company's shares have traded in a range of $61.86 to $80.41.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates. Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
RELATED NEWS
Follow RTT